A randomized controlled trial comparing a digitally delivered gut-directed hypnotherapy (GDH) program (Nerva) to an active control found that GDH significantly improved IBS symptoms and quality of life. Among 240 participants, 81% of those using the GDH program experienced a ≥50-point decrease in IBS symptom severity compared to 63% in the control group (P = 0.002). GDH also led to a greater reduction in pain (71% vs. 35%, P < 0.001) and quality-of-life improvements (P < 0.001). These findings support digital GDH as an effective and accessible alternative to in-person behavioral interventions for IBS management.
Trending
- The Frontiers of EUS in 2026: A Focus on Novel Needle-Based Devices (GI & Endoscopy News)
- Hybrid Deep Learning Improves Gastrointestinal Image Classification (European Medical Journal)
- Participation in stool-based screening program cut colorectal cancer mortality by 43% (Healio)
- World’s First Fully Robotic Transoral Gastric Procedures Completed Using EndoQuest’s Endoluminal Surgical System (Business Wire)
- Lucid Diagnostics Announces Publication of Landmark 12,000-Patient Real-World EsoGuard® Study (PR Newswire)
- Private equity and corporate medicine: what physicians say, in their own words (KevinMD)
- Serrated polyposis often goes unrecognized, task force says (GI & Hepatology News)
- Studies Suggest Longer Colonoscopy Surveillance Intervals May Be Safe (Medscape)
